Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1601122

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1601122

Nutraceutical Ingredients Market by Form (Dry, Liquid), Health Benefits (Bone Health, Cognitive Performance, Gut Health), Type, Application - Global Forecast 2025-2030

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Nutraceutical Ingredients Market was valued at USD 209.79 billion in 2023, expected to reach USD 227.81 billion in 2024, and is projected to grow at a CAGR of 8.78%, to USD 378.21 billion by 2030.

The nutraceutical ingredients market encompasses bioactive compounds formulated for health benefits beyond traditional nutrition. These ingredients, extracted from natural sources such as fruits, vegetables, herbs, and marine sources, are integral to functional foods, beverages, dietary supplements, and personal care products. Nutraceuticals are increasingly vital amid rising health awareness, aging populations, and increased incidence of chronic diseases, driving demand for natural, preventive healthcare solutions. The application and end-use scope is broad, spanning pharmaceuticals, functional food and beverages, dietary supplements, and animal nutrition, each leveraging the health-promoting properties of these bioactives. Key growth influencers include increasing consumer preference for natural products, regulatory support for clinically substantiated health claims, and technological advancements in extraction and formulation methods. The market faces challenges such as stringent regulatory compliance, high costs of research and product development, and varying regional definitions and standards for nutraceuticals, impacting the ease of market entry and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 209.79 billion
Estimated Year [2024] USD 227.81 billion
Forecast Year [2030] USD 378.21 billion
CAGR (%) 8.78%

Emerging opportunities lie in personalized nutrition, leveraging AI and big data for tailor-made nutraceutical solutions based on genetic and lifestyle factors; clean label products, driven by consumer demand for transparency and sustainability; and the expanding role of e-commerce in reaching wider audiences. To capitalize on these opportunities, companies should invest in robust R&D to support health claims, foster partnerships with biotech firms for innovation, and engage in educational marketing to build consumer trust and awareness. Innovations could focus on novel ingredient sources like algae and microorganisms, bioavailability enhancement techniques, and the integration of digital health tools for personalized consumer experiences. The nutraceutical market is dynamic and competitive, marked by rapid advancements and consumer-driven trends. Companies should remain agile, aligning with regulatory shifts and consumer preferences to harness the market's full potential. Emphasizing sustainability, transparency, and evidence-based benefits will be critical in navigating this multifaceted market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nutraceutical Ingredients Market

The Nutraceutical Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased Life Expectancy and Health Consciousness Among Consumers
    • Need of Nutraceutical Products for Wellbeing of Chronic Disease Patients
    • Diverse Applications in Sports Nutrition and Cosmeceutical
  • Market Restraints
    • Low Awareness about Nutraceuticals and Higher Cost of Fortified and Rich-ingredient Products
  • Market Opportunities
    • Emergence of Advancements and Innovation in the Products
    • Government Initiative to Promote Healthy Diets
  • Market Challenges
    • High R&D Cost of Nutraceutical Ingredients
    • Varying Regulatory Standards Across Different Countries

Porter's Five Forces: A Strategic Tool for Navigating the Nutraceutical Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nutraceutical Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nutraceutical Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nutraceutical Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nutraceutical Ingredients Market

A detailed market share analysis in the Nutraceutical Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nutraceutical Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nutraceutical Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Nutraceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Alticor Global Holdings Inc., Amway Corporation, Archer-Daniels-Midland Company, Arla Foods amba, Associated British Foods PLC, Balchem Corporation, Barentz International B.V., BASF SE, BIONAP S.R.L., Cargill, Incorporated, Chr. Hansen Holding A/S, ChromaDex, Inc., Danone S.A., Divi's Laboratories Limited, DuPont de Nemours, Inc., Fonterra Co-operative Group Limited, Glanbia PLC, Ingredion Incorporated, Kerry Group PLC, Koninklijke DSM N.V., Kyowa Kirin Co., Ltd., Lonza Group, Martin Bauer Group, Nestle S.A., Pfizer Inc., Sydler India Pvt. Ltd., Tate & Lyle PLC, and ZIVO Bioscience, Inc..

Market Segmentation & Coverage

This research report categorizes the Nutraceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Dry and Liquid.
  • Based on Health Benefits, market is studied across Bone Health, Cognitive Performance, Gut Health, Heart Health, Immunity, Nutrition, and Weight Management. The Cognitive Performance is further studied across Sleep Boosting and Stress Management.
  • Based on Type, market is studied across Carotenoids, Fibers & Specialty Carbohydrates, Minerals, Omega-3 Fatty Acids, Phytochemical & Plant Extracts, Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins.
  • Based on Application, market is studied across Animal Nutrition, Dietary Supplements, Functional Beverages, Functional Foods, and Personal Care.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-430D3EB72AEB

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Life Expectancy and Health Consciousness Among Consumers
      • 5.1.1.2. Need of Nutraceutical Products for Wellbeing of Chronic Disease Patients
      • 5.1.1.3. Diverse Applications in Sports Nutrition and Cosmeceutical
    • 5.1.2. Restraints
      • 5.1.2.1. Low Awareness about Nutraceuticals and Higher Cost of Fortified and Rich-ingredient Products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of Advancements and Innovation in the Products
      • 5.1.3.2. Government Initiative to Promote Healthy Diets
    • 5.1.4. Challenges
      • 5.1.4.1. High R&D Cost of Nutraceutical Ingredients
      • 5.1.4.2. Varying Regulatory Standards Across Different Countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Demand for dry form nutraceutical ingredients due to longer shelf life
    • 5.2.2. Application: Employment across dietary supplements for development of personalized nutrition
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Nutraceutical Ingredients Market, by Form

  • 6.1. Introduction
  • 6.2. Dry
  • 6.3. Liquid

7. Nutraceutical Ingredients Market, by Health Benefits

  • 7.1. Introduction
  • 7.2. Bone Health
  • 7.3. Cognitive Performance
    • 7.3.1. Sleep Boosting
    • 7.3.2. Stress Management
  • 7.4. Gut Health
  • 7.5. Heart Health
  • 7.6. Immunity
  • 7.7. Nutrition
  • 7.8. Weight Management

8. Nutraceutical Ingredients Market, by Type

  • 8.1. Introduction
  • 8.2. Carotenoids
  • 8.3. Fibers & Specialty Carbohydrates
  • 8.4. Minerals
  • 8.5. Omega-3 Fatty Acids
  • 8.6. Phytochemical & Plant Extracts
  • 8.7. Prebiotics
  • 8.8. Probiotics
  • 8.9. Proteins & Amino Acids
  • 8.10. Vitamins

9. Nutraceutical Ingredients Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Dietary Supplements
  • 9.4. Functional Beverages
  • 9.5. Functional Foods
  • 9.6. Personal Care

10. Americas Nutraceutical Ingredients Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nutraceutical Ingredients Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nutraceutical Ingredients Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. CoreFX Ingredients acquires Connoils to drive innovation and customer-centric growth in the nutraceutical ingredients market
    • 13.3.2. Roquette Pharma Solutions introduces LYCAGEL Flex, a plant-based hydroxypropyl pea starch for efficient and stable soft gel capsules
    • 13.3.3. Roquette Launches Three Moisture-Protecting Ingredients for Nutraceuticals at CPhI Barcelona
    • 13.3.4. Lubrizol Launches Carbopol Polymers for Nutraceuticals with New EU Food Grade Approval
    • 13.3.5. Sabinsa Opens New Facility for Nutraceutical and Pharmaceutical Ingredients

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. Alticor Global Holdings Inc.
  • 3. Amway Corporation
  • 4. Archer-Daniels-Midland Company
  • 5. Arla Foods amba
  • 6. Associated British Foods PLC
  • 7. Balchem Corporation
  • 8. Barentz International B.V.
  • 9. BASF SE
  • 10. BIONAP S.R.L.
  • 11. Cargill, Incorporated
  • 12. Chr. Hansen Holding A/S
  • 13. ChromaDex, Inc.
  • 14. Danone S.A.
  • 15. Divi's Laboratories Limited
  • 16. DuPont de Nemours, Inc.
  • 17. Fonterra Co-operative Group Limited
  • 18. Glanbia PLC
  • 19. Ingredion Incorporated
  • 20. Kerry Group PLC
  • 21. Koninklijke DSM N.V.
  • 22. Kyowa Kirin Co., Ltd.
  • 23. Lonza Group
  • 24. Martin Bauer Group
  • 25. Nestle S.A.
  • 26. Pfizer Inc.
  • 27. Sydler India Pvt. Ltd.
  • 28. Tate & Lyle PLC
  • 29. ZIVO Bioscience, Inc.
Product Code: MRR-430D3EB72AEB

LIST OF FIGURES

  • FIGURE 1. NUTRACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NUTRACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NUTRACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUTRACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUTRACEUTICAL INGREDIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BONE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SLEEP BOOSTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STRESS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY GUT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY IMMUNITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY CAROTENOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS & SPECIALTY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PHYTOCHEMICAL & PLANT EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROTEINS & AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NUTRACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 247. NUTRACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!